EMVision Medical Devices Ltd (ASX:EMV)
Australia · Delayed Price · Currency is AUD 2.000
-0.010 (-0.50%)
Aug 29, 2025, 4:10 PM AEST
EMVision Medical Devices Company Description
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia.
The company offers non-invasive brain scanners bedside device emu, an ultra-light weight first responder pre-hospital device.
EMVision Medical Devices Ltd was incorporated in 2017 and is based in Macquarie Park, Australia.
EMVision Medical Devices Ltd
| Country | Australia |
| Founded | 2017 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Scott Kirkland |
Contact Details
Address: 65 Epping Road Macquarie Park, 2113 Australia | |
| Phone | 61 2 8667 5337 |
| Website | emvision.com.au |
Stock Details
| Ticker Symbol | EMV |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000028375 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Scott Kirkland | Chief Executive Officer, MD and Executive Director |
| Emma Waldon | Chief Financial Officer and Company Secretary |
| Forough Khandan | Chief Technology Officer |
| Prof. Stuart Crozier B.E., M.Sc., Ph.D. | Chairman of Clinical Advisory Board and Chief Scientific Officer |
| Robert Tiller | Head of Design |
| Dr. Konstanty Bialkowski | Head of Tech Development |
| Dr. Christian Wight | Head of Regulatory Affairs |